Skip to main content
. 2021 Dec 2;12:747228. doi: 10.3389/fpsyt.2021.747228

Table 5.

Associations of folate deficiency (<3 ng/mL) with suicidal behavior in patients with depressive disorder.

Suicidal behavior Folate level N patient N (%) presence of suicidal behavior Odds ratio (95% confidence interval)
Unadjusted Adjusteda
Present previous suicidal attempt Normal range 1,016 80 (7.9) Ref Ref
Deficiency 78 16 (20.5) 3.02 (1.67–5.48) 2.32 (1.18–4.49)*
Higher baseline suicidal severity Normal range 1,016 322 (31.7) Ref Ref
Deficiency 78 40 (51.3) 2.27 (1.43–3.61) 2.23 (1.34–3.69)
Increased suicidal severity during follow-up Normal range 819 138 (16.8) Ref Ref
Deficiency 65 17 (26.2) 1.75 (0.98–3.13) 1.42 (0.77–2.64)
Fatal/non-fatal suicidal attempt during follow-up Normal range 819 29 (3.5) Ref Ref
Deficiency 65 9 (13.8) 4.38 (1.98–9.70) 2.84 (1.19–6.77)*

Baseline suicidal severity was defined using the brief psychiatric rating scale (BPRS) suicidality item scores, divided into lower [1 (not present) ~ 3 (mild)] and higher [4 (moderate) ~ 7 (extremely severe)]. Increased suicidal severity was defined as any instance in the increase in BPRS suicidality item score during 12-month pharmacotherapy.

a

Adjusted for age, sex, marital state, religious affiliation, monthly income, atypical feature, number of previous depressive episode, use vitamin supplement, and scores on Hospital Anxiety and Depression Scale-anxiety subscale and Alcohol Use Disorders Identification Test for baseline analyses, plus treatment steps over 12-month pharmacotherapy for follow-up analyses.

*

P < 0.05;

P < 0.01;

P < 0.001.